Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: Report of three cases
- 1 April 2006
- journal article
- case report
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 64 (5), 1295-1298
- https://doi.org/10.1016/j.ijrobp.2005.12.004
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2005
- High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200Journal of Clinical Oncology, 2005
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerThe New England Journal of Medicine, 2004
- Current concepts in radiation enteritis and implications for future clinical trialsCancer, 2002
- Tolerance of normal tissue to therapeutic irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1991